Insiders · ATNM

ATNM insider transactions

Actinium Pharmaceuticals Inc. (Delaware) (ATNM) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ATNM

• 292d
  Chief Executive Officer Seth Sandesh covered exercise/tax liability with 120,900 shares, decreasing direct ownership by 40% to 184,481 units (SEC Form 4)

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 432d
  SEC Form 4 filed by Director Steinhart Richard I

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 432d
  SEC Form 4 filed by Director Chell Jeffrey W.

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 432d
  SEC Form 4 filed by Director Almenoff June Sherie

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 432d
  SEC Form 4 filed by Director Nicholson, C. David

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 432d
  SEC Form 4 filed by Director Shetty Ajit

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 432d
  SEC Form 4 filed by Chief Executive Officer Seth Sandesh

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 432d
  SEC Form 4 filed by Chief Financial Officer O'Loughlin Steve

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 580d
  SEC Form 4 filed by Director Almenoff June Sherie

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 580d
  SEC Form 3 filed by new insider Almenoff June Sherie

  3 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 892d
  SEC Form 4 filed by Nicholson, C. David

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 892d
  SEC Form 4 filed by Steinhart Richard I

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 892d
  SEC Form 4 filed by O'Loughlin Steve

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 892d
  SEC Form 4 filed by Shetty Ajit

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 892d
  SEC Form 4 filed by Seth Sandesh

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 892d
  SEC Form 4 filed by Chell Jeffrey W.

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1389d
  SEC Form 4: Seth Sandesh was granted 300,000 shares, increasing direct ownership by 5,575% to 305,381 units

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1438d
  SEC Form 4 filed by O'Loughlin Steve

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1438d
  SEC Form 4 filed by Nicholson, C. David

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1438d
  SEC Form 4 filed by Steinhart Richard I

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1438d
  SEC Form 4 filed by Shetty Ajit

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1438d
  SEC Form 4 filed by Seth Sandesh

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1438d
  SEC Form 4 filed by Chell Jeffrey W.

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1739d
  SEC Form 4 filed by Chell Jeffrey W.

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1739d
  SEC Form 4 filed by Berger Mark Stanley

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1739d
  SEC Form 4 filed by Shetty Ajit

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1739d
  SEC Form 4 filed by O'Loughlin Steve

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1739d
  SEC Form 4 filed by Steinhart Richard I

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1739d
  SEC Form 4 filed by Seth Sandesh

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)
• 1739d
  SEC Form 4 filed by Nicholson, C. David

  4 - Actinium Pharmaceuticals, Inc. (0001388320) (Issuer)